Jpmorgan Chase & CO Ptc Therapeutics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 562,781 shares of PTCT stock, worth $25.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
562,781
Previous 680,933
17.35%
Holding current value
$25.4 Million
Previous $20.8 Million
0.27%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78.1MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$412 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$356 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$351 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$334 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$327 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.23B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...